Rhythm Pharmaceuticals Inc’s filing revealed that its Chief Financial Officer Smith Hunter C unloaded Company’s shares for reported $3.39 million on Jul 09 ’25. In the deal valued at $80.48 per share,42,120 shares were sold. As a result of this transaction, Smith Hunter C now holds 116,915 shares worth roughly $10.02 million.
Then, Shulman Joseph sold 7,969 shares, generating $619,851 in total proceeds. Upon selling the shares at $77.78, the Chief Technical Officer now owns 8,509 shares.
Before that, German Christopher Paul sold 3,817 shares. Rhythm Pharmaceuticals Inc shares valued at $308,217 were divested by the Corporate Controller & CAO at a price of $80.75 per share. As a result of the transaction, German Christopher Paul now holds 922 shares, worth roughly $78996.96.
Goldman initiated its Rhythm Pharmaceuticals Inc [RYTM] rating to a Buy in a research note published on July 10, 2025; the price target was $97. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in early July with a ‘”an Outperform”‘ rating. BofA Securities also remained covering RYTM and has increased its forecast on April 07, 2025 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of RYTM
On Monday, Rhythm Pharmaceuticals Inc [NASDAQ:RYTM] saw its stock fall -0.89% to $85.68. Over the last five days, the stock has lost -3.33%. Rhythm Pharmaceuticals Inc shares have risen nearly 73.72% since the year began. Nevertheless, the stocks have risen 53.05% over the past one year. While a 52-week high of $94.80 was reached on 07/10/25, a 52-week low of $40.61 was recorded on 04/07/25.
Levels Of Support And Resistance For RYTM Stock
The 24-hour chart illustrates a support level at 84.31, which if violated will result in even more drops to 82.93. On the upside, there is a resistance level at 86.97. A further resistance level may holdings at 88.25.
How much short interest is there in Rhythm Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc stocks on 2025-07-15, growing by 32000.0 shares to a total of 4.79 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 4.76 million shares. There was a rise of 0.67%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 02, 2025 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $80 price target.
